_version_ 1783410649359974400
author Falconi, Giulia
Fabiani, Emiliano
Piciocchi, Alfonso
Criscuolo, Marianna
Fianchi, Luana
Lindfors Rossi, Elisa L.
Finelli, Carlo
Cerqui, Elisa
Ottone, Tiziana
Molteni, Alfredo
Parma, Matteo
Santarone, Stella
Candoni, Anna
Sica, Simona
Leone, Giuseppe
Lo-Coco, Francesco
Voso, Maria Teresa
author_facet Falconi, Giulia
Fabiani, Emiliano
Piciocchi, Alfonso
Criscuolo, Marianna
Fianchi, Luana
Lindfors Rossi, Elisa L.
Finelli, Carlo
Cerqui, Elisa
Ottone, Tiziana
Molteni, Alfredo
Parma, Matteo
Santarone, Stella
Candoni, Anna
Sica, Simona
Leone, Giuseppe
Lo-Coco, Francesco
Voso, Maria Teresa
author_sort Falconi, Giulia
collection PubMed
description
format Online
Article
Text
id pubmed-6462855
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64628552019-06-25 Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes Falconi, Giulia Fabiani, Emiliano Piciocchi, Alfonso Criscuolo, Marianna Fianchi, Luana Lindfors Rossi, Elisa L. Finelli, Carlo Cerqui, Elisa Ottone, Tiziana Molteni, Alfredo Parma, Matteo Santarone, Stella Candoni, Anna Sica, Simona Leone, Giuseppe Lo-Coco, Francesco Voso, Maria Teresa Leukemia Brief Communication Nature Publishing Group UK 2018-10-05 2019 /pmc/articles/PMC6462855/ /pubmed/30291338 http://dx.doi.org/10.1038/s41375-018-0284-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Brief Communication
Falconi, Giulia
Fabiani, Emiliano
Piciocchi, Alfonso
Criscuolo, Marianna
Fianchi, Luana
Lindfors Rossi, Elisa L.
Finelli, Carlo
Cerqui, Elisa
Ottone, Tiziana
Molteni, Alfredo
Parma, Matteo
Santarone, Stella
Candoni, Anna
Sica, Simona
Leone, Giuseppe
Lo-Coco, Francesco
Voso, Maria Teresa
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
title Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
title_full Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
title_fullStr Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
title_full_unstemmed Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
title_short Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
title_sort somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462855/
https://www.ncbi.nlm.nih.gov/pubmed/30291338
http://dx.doi.org/10.1038/s41375-018-0284-9
work_keys_str_mv AT falconigiulia somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT fabianiemiliano somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT piciocchialfonso somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT criscuolomarianna somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT fianchiluana somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT lindforsrossielisal somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT finellicarlo somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT cerquielisa somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT ottonetiziana somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT moltenialfredo somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT parmamatteo somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT santaronestella somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT candonianna somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT sicasimona somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT leonegiuseppe somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT lococofrancesco somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes
AT vosomariateresa somaticmutationsasmarkersofoutcomeafterazacitidineandallogeneicstemcelltransplantationinhigherriskmyelodysplasticsyndromes